Pancreatic lymphôma – case report

Vu Thi Hang1, Nguyen Trong Son2, Le Thanh Dung1, Nguyen Duy Hue1, Dinh Tho1,
1 Viet Duc hospital
2 Viet Duc Hospital

Main Article Content

Abstract

SUMMARY
Pancreatic Lymphôma is most commonly a B-cell sub-type of non-Hodgkin lymphôma and is classified as either primary or secondary. We describe a case secondary Pancreatic lymphôma in a 64-year-old woman who presented with abdominal pain and weight loss for one month. Her laboratory tests upon admission were as follows : white blood
cell count 9.6 G/l (reference range: 4,0-10,0), red blood cell 4.5 T/l (reference range: 3.8-5.8. The tumor marker levels of CEA; CA 125, CA 15-3, CA 19-9, αFP were all within the normal range. Abdominal ultrasound usually shows only a spenlic mass and many lymphô node in the abdomen. Gastroscopy and colonoscopy were normal. Abdominal multi slice computed tomography (MSCT) revealed a mass in the pancreatic body - tail and splenn suggest infarct lesions. There were many lymphadenopathies located at the portal hilus, para-aortic region and left renal hilus. PET/CT showed all lesions on the MSCT increased metabolic activity with maximal standardized uptake values (SUVmax) ranging from 8.9 to 17.0. Laparoscopy biopsy of pancreatic mass be performed to establish the diagnosis. In reports was extranodal marginal zone B cell lymphôma. The PET/CT after treatment 2 months suggest the disease respond well to treatment.

Article Details

References

TÀI LIỆU THAM KHẢO
1. Carmel G. Cronin et al (2010) “Clinical Utility of PET/CT in Lymphoma” AJR; 194:W91–W103.
2. Dominique Delbeke, MD, PhD (2009) “PET and PET/CT in Lymphoma and Monitoring Therapy” VUMC PET/CT Conference.
3. Elmar M. Merkle et al (2000) “Imaging Findings in Pancreatic Lymphoma: Differential Aspects” AJR:174.
4. Fabio M. Paes, MD et al (2010) “FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease” RadioGraphics; 30:253–267.
5. Henry Knipe and Bruno Di Muzio et al “Pancreatic
lymphoma” http://radiopaedia.org/articles/pancreaticlymphoma.
6. M Wasif Saif (2007) “Secondary pancreatic involvement by a diffuse large B-cell lymphoma presenting as acute pancreatitis” World J Gastroenterol; 13(36): 4909-4911.
7. Martin Hutchings and Sally F. Barrington (2009) “PET/CT for Therapy Response Assessment in Lymphoma” J Nucl Med; 50:21S–30S.
8. Parra CM, Tomich GR, et al (2012) “PET/CT of extranodal involvement in lymphoma” Revista Argentina de Diagnóstico por Imágene, Volume 1, number 1.
9. Taylan Kav et al (2010) “Primary Pancreatic Lymphoma or Secondary Involvement: What Is the Difference?” J Pancreas; 11(5):482-483.
10. Vien X Nguyen et al (2011) “18F-FDG PET/ CT Imaging of the Pancreas: Spectrum of Diseases” J Pancreas; 12(6):557-566.